79 results
10-K
2019 FY
EX-10.5
CRXM
Gene Biotherapeutics, Inc.
Annual report
23 Apr 21
2:24pm
8-K
EX-10.3
CRXM
Gene Biotherapeutics, Inc.
28 May 20
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
4:05pm
8-K
EX-10.4
CRXM
Gene Biotherapeutics, Inc.
28 May 20
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
4:05pm
8-K
EX-10.5
CRXM
Gene Biotherapeutics, Inc.
28 May 20
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
4:05pm
8-K
EX-10.2
CRXM
Gene Biotherapeutics, Inc.
28 May 20
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
4:05pm
8-K
EX-10.1
y12cz
28 May 20
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
4:05pm
8-K
EX-10.1
22xe82
27 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
v95a1k2faptbv3mtm56s
11 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
9tn 092tbp
11 Jul 16
Angionetics & a Huapont Life Sciences Affiliate Enter Agreement
12:00am
8-K
EX-10.2
cmoxatq3rcv8hud
11 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
6xcwlv8yr 7bamc
11 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
q6b73
23 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
dldn4w5a
4 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
nqdgigs33 lhz5
4 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
lu6xgpy7mmpwcsjsgio
21 Nov 13
Cardium’s to Go Brands Acquired by
12:00am
8-K
EX-10.3
uw6uyxkq kgolw7pq
5 Apr 13
Cardium Announces $4.0 Million Preferred Stock Financing
12:00am
8-K
EX-10.1
v4afq d2lga
5 Apr 13
Cardium Announces $4.0 Million Preferred Stock Financing
12:00am
8-K
EX-10.1
3khkrn1i4 i9zums
4 Oct 12
Cardium Announces the Acquisition of to Go Brands
12:00am